Instituto de Estudios Políticos y Derecho Público "Dr. Humberto J. La Roche"
de la Facultad de Ciencias Jurídicas y Políticas de la Universidad del Zulia
Maracaibo, Venezuela
Publicación cientíca en formato digital
ISSN-Versión Impresa 0798-1406 / ISSN-Versión on line 2542-3185
Depósito legal pp 197402ZU34
ppi 201502ZU4645
Vol.40 N° 74
2022
Recibido el 15/05/2022 Aceptado el 12/08/2022
ISSN 0798- 1406 ~ De pó si to le gal pp 198502ZU132
Cues tio nes Po lí ti cas
La re vis ta Cues tio nes Po lí ti cas, es una pu bli ca cn aus pi cia da por el Ins ti tu to
de Es tu dios Po lí ti cos y De re cho Pú bli co Dr. Hum ber to J. La Ro che” (IEPDP) de la Fa-
cul tad de Cien cias Ju rí di cas y Po ti cas de la Uni ver si dad del Zu lia.
En tre sus ob je ti vos fi gu ran: con tri buir con el pro gre so cien tí fi co de las Cien cias
Hu ma nas y So cia les, a tra vés de la di vul ga ción de los re sul ta dos lo gra dos por sus in ves-
ti ga do res; es ti mu lar la in ves ti ga ción en es tas áreas del sa ber; y pro pi ciar la pre sen ta-
ción, dis cu sión y con fron ta ción de las ideas y avan ces cien tí fi cos con com pro mi so so cial.
Cues tio nes Po lí ti cas apa re ce dos ve ces al o y pu bli ca tra ba jos ori gi na les con
avan ces o re sul ta dos de in ves ti ga ción en las áreas de Cien cia Po lí ti ca y De re cho Pú bli-
co, los cua les son so me ti dos a la con si de ra ción de ár bi tros ca li fi ca dos.
ESTA PU BLI CA CIÓN APA RE CE RE SE ÑA DA, EN TRE OTROS ÍN DI CES, EN
:
Re vicyhLUZ, In ter na tio nal Po li ti cal Scien ce Abs tracts, Re vis ta In ter ame ri ca na de
Bi blio gra fía, en el Cen tro La ti no ame ri ca no para el De sa rrol lo (CLAD), en Bi blio-
gra fía So cio Eco nó mi ca de Ve ne zue la de RE DIN SE, In ter na tio nal Bi blio graphy of
Po li ti cal Scien ce, Re vencyt, His pa nic Ame ri can Pe rio di cals In dex/HAPI), Ul ri chs
Pe rio di cals Di rec tory, EBS CO. Se en cuen tra acre di ta da al Re gis tro de Pu bli ca cio-
nes Cien tí fi cas y Tec no ló gi cas Ve ne zo la nas del FO NA CIT, La tin dex.
Di rec to ra
L
OIRALITH
M. C
HIRINOS
P
ORTILLO
Co mi Edi tor
Eduviges Morales Villalobos
Fabiola Tavares Duarte
Ma ría Eu ge nia Soto Hernández
Nila Leal González
Carmen Pérez Baralt
Co mi Ase sor
Pedro Bracho Grand
J. M. Del ga do Ocan do
Jo Ce rra da
Ri car do Com bel las
An gel Lom bar di
Die ter Nohlen
Al fre do Ra mos Ji mé nez
Go ran Ther born
Frie drich Welsch
Asis ten tes Ad mi nis tra ti vos
Joan López Urdaneta y Nil da Ma n
Re vis ta Cues tio nes Po lí ti cas. Av. Gua ji ra. Uni ver si dad del Zu lia. Nú cleo Hu ma nís ti co. Fa-
cul tad de Cien cias Ju rí di cas y Po lí ti cas. Ins ti tu to de Es tu dios Po lí ti cos y De re cho Pú bli co
Dr. Hum ber to J. La Ro che. Ma ra cai bo, Ve ne zue la. E- mail: cues tio nes po li ti cas@gmail.
com ~ loi chi ri nos por til lo@gmail.com. Te le fax: 58- 0261- 4127018.
Vol. 40, Nº 74 (2022), 207-223
IEPDP-Facultad de Ciencias Jurídicas y Políticas - LUZ
Legal Responsibility for Illicit Trade in
Pharmaceuticals under Conditions of the
Covid-19 Pandemic
DOI: https://doi.org/10.46398/cuestpol.4074.11
Mariia Shcherbina *
Mykhailo Akimov **
Iryna Ozerna ***
Ilgar Huseynov ****
Halyna Rossikhina *****
Abstract
The aim of this study was to examine the optimal types and

       
The research used methods of systematic approach, descriptive
analysis, synthesis and prognosis, systematic and formal legal
and comparative selection. It has been established that illicit trade in
pharmaceuticals is carried out by organized criminal groups and is related to


compliance with international standards of criminalization and imposition
of sanctions for illegal circulation of counterfeit medicines. All this leads
to the conclusion that the illicit trade in pharmaceuticals manifests itself

be foreseen. Equally promising is the development of a model for law
enforcement activity that includes criminalization of trade in low-quality,
unregistered and counterfeit pharmaceuticals, according to international
       
measures for legal persons and compensation for their victims.
* Postgraduate student, Criminal, Civil and International Law Department, Zaporizhzhia Polytechnic


** PhD in Legal Sciences, Associate Professor, Criminal Law Department, National Academy of Internal

*** PhD in Law, Assocciate Professor, Department of State and Law Sciences and Public Management,
            

  

       
        

208
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic
Keywords:      
legal liability; organized crime.
Responsabilidad Jurídica por Comercio Ilícito de
Productos Farmacéuticos en Condiciones de la Pandemia

Resumen
El objetivo de este estudio fue examinar los tipos y medidas óptimos
de responsabilidad legal por delitos en el campo del comercio ilícito de
        
La investigación utilizó métodos de enfoque sistemático, análisis
descriptivo, síntesis y pronóstico, selección sistemática y legales formales
y comparativos. Se ha establecido que el comercio ilícito de productos
farmacéuticos es realizado por grupos delictivos organizados y se relaciona
con la corrupción y el delito cibernético. También el artículo ha revelado
fallas legales típicas, que complican la cooperación internacional en este
campo y conducen al incumplimiento de los estándares internacionales
de criminalización e imposición de sanciones por la circulación ilegal de
   
    
que debe preverse la responsabilidad administrativa o penal. Igualmente es
prometedor el desarrollo de un modelo para la actividad de aplicación de la
ley que incluya la criminalización del comercio de productos farmacéuticos
         
internacionales; castigos proporcionales a las personas físicas y medidas

estos.
Palabras clave: 
mercados ilegales; responsabilidad legal; crimen
organizado.
Introduction
  
similar to other rights recognized by the international community. Patient
safety is the most important component of the provision of medical care
(Shojaei and Salari, 2020) 
countries of the world.

CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223





of counterfeit drugs in treatment protocols alongside legal medications.

mortality rate increases (Haji et al., 2021). However, the illegal circulation
of medicines has an extremely negative impact not only on the health of the
population but also on the economic situation. In particular, the growth of
the markets for counterfeit pharmaceuticals may exceed $ 16.04 trillion in
2030 with the prospect of increasing to $ 24.24 trillion in 2040 (,
et al., 2021).

         
       



of the vast majority of countries (Europol, 2020c). However, due to the
illicit trade in pharmaceuticals, the pandemic has become more destructive
to the lives, health, and well-being of the elderly, people with serious
concomitant diseases, and persons with low socio-economic status (United
Nations, 2020).
At the same time, the real volume of illegal circulation of counterfeit
medicine can be assessed only partially. Analysis by UN experts showed
that some countries did not register the production or distribution of

          
2021). However, you can use the law enforcement data. Thus, under the
coordination of Interpol, more than 34,000 counterfeit medical products

Director-General
  

         

the close connection of this illegal activity with international economic and

Salazar, 2021).
       
has highlighted many interrelated law enforcement problems, such as
210
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic
an increase in the level of cybercrime. Under quarantine restrictions,
governments have allowed online sales of medicine and medical supplies,
as well as direct delivery to customers, to comply with the transportation
     



Enterprises that wanted to buy consumables and protective equipment



          
       
  
health care system is a global problem that creates optimal conditions for

Crime, 2021).
        
         
        

in the public health and criminal justice systems. They use uncertainty
among the public and authorities to create demand for scarce medicine
and to 
   

        
of illicit trade in pharmaceuticals led to the inclusion in this activity of
criminal groups that were engaged in the drug business (United Nations

        
transnational organized criminal activity was formed. This determines the
mainstreaming of the issues of countering it with measures of legal liability,
       et al.,
2021).


proper investigative procedures and subsequent judicial trials of cases.
Since such crimes can be transnational and complex, this requires the
provision of expert opinions and legal assistance from other countries

211
CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223
Today, the only specialized international document on combating crime

medical products and similar crimes involving threats to public health
(Elliott et al., 2020; Medicrim, 2011). It determines the need to criminalize
         

approved drugs (The Council of Europe, 2021).
But to this day, there is no general understanding of the seriousness
of the problem. In particular, pharmaceutical companies are trying to
independently counter the counterfeiting of medicinal products through
the introduction of potential protection measures (Haji et al., 2021). In

for inadequate penalties, or do not include crimes related to the circulation
 

       




of trade in counterfeit medicines on online platforms (Interpol, 2020;
et al., 2020).
         
of legal responsibility is extremely unfavourable, as in the future, the
world will face new epidemics and pandemics. Therefore, we cannot allow
repetition of the situation when the society again will not be ready for stable
functioning in the conditions of the crisis (Borysov, 2021).
Although at the international and regional levels, authoritative structures

patient safety (Haji et al., 2021), the issue of legal liability for illicit trade

relevance.
          
           
and adequate measures of legal liability for their commission. It is also
considered important to identify the prospects for the development of these

      purpose of this study is to

pandemic as an illegal behaviour with the development of appropriate
 

212
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic
        
          
         
        
using legal liability.
1. Methodology and methods

of literature and data of law enforcement practice; analysis of the material,
presented in the selected sources, and evaluation of the results of these


pharmaceuticals; determination of the purpose of the article; formulation
of conclusions and practical recommendations for the formation of the
  

This study used international legal standards regarding the types of legal
liability for illicit trade in pharmaceuticals, and generalization of regional
and international law enforcement practice in countering it, including in the



legal liability.
           
the method of the systemic approach was used to consider illicit trade in
pharmaceuticals as a component of the shadow economy, on the one hand,
the method of
descriptive analysis was used to determine the types of legal liability for illicit

methods of synthesis and forecasting were used to determine the prospects


legal liability; the method of systematic selection and comparison method
were used to select and compare law enforcement practices countering
illicit trade in pharmaceuticals; the formal-legal method made it possible
to study the peculiarities of illicit trade in pharmaceuticals as a basis for the
application of various types of legal liability.
213
CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223
2. Results
The analysis of legal liability for illicit trade in pharmaceuticals under


to such trade as grounds for legal liability; b) types of legal liability for these


that can be included in the concept of “illicit trade in pharmaceuticals”, as
it provides for the understanding of both a criminal act and the object for
which it was committed. Trade per se means a certain stage of the activity
of bringing the medicinal product to the consumer and it is made illegal by
the object – the peculiarities of the medicinal product.
       
        
       
authorized medicinal products that do not meet quality standards and/
or technical conditions; b) unregistered medical products are medical
products that have not undergone evaluation and/or approval by a national
         
         
composition or source of which were intentionally distorted (World Health
 
through legal activities (see Figure 1).
Figure 1: Oenses related to the illicit trade in pharmaceuticals
         
      
counterfeiting of medical products and similar crimes involving threats to
public health of 2011 (The Council of Europe, 2011).
214
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic
Illicit trade in pharmaceuticals is often equated with other crimes, as it
is a complex, sometimes long-term action, combined with other types of
         
 2).
Figure 2: The ratio of oenses in the eld of illicit trade in pharmaceuticals and
related oenses (European Union Agency for Criminal Justice Cooperation,
2021: 21; Europol, 2020a: 3; Europol, 2020c: 8; Haji et al., 2021: 8; United
Nations Oce on Drugs and Crime, 2021: 13, 19).
As already mentioned, the illicit trade in pharmaceuticals is part of the
shadow activities carried out by organized criminal groups. This is due
to the complexity of processes in the pharmaceutical industry. However,
  
pandemic. Quarantine hurt the organization of activities of pharmaceutical
companies, which had to respond promptly to a sharp increase in demand
for certain types of goods. In addition, quarantine restrictions adversely
et al., 2020).
           

215
CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223
et al
of supply chains from manufacturers to distributors allowed criminals to
et al., 2021). Accordingly, various
types of economic chains were formed depending on the capabilities of
organized criminal groups (see Figure 3).
Figure 3: Economic chains involving organized criminal groups in the eld of
illicit trade in pharmaceuticals (Europol, 2020c: 9)



            
the establishment of administrative liability in the case of illicit trade in
legal medications. However, in other cases, criminal liability should be
established.
Complex organized criminal groups often use corporate structures
        
Therefore, it is necessary to introduce the responsibility of legal entities

(direct actors) and legal entities shall be subject to criminal liability. A
general approach to legal liability measures can be seen in Figure 4.

        
business for criminals. When setting sanctions and imposing punishment,
            
received by the criminal, and the potential harm to public health should be
216
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic





Figure 4: Legal responsibility for falsied medical product-related crimes
(United Nations Oce on Drugs and Crime, 2019: 42)
In addition, victims of crimes should be compensated for the damage
caused by the illicit trade in pharmaceuticals.
          
expediency of developing a model of legal liability for illicit trade in

transnational nature of this activity, it is reasonable to focus on a general

      Good Legislative Practices on
Combating Falsied Medical Product-Related Crime (United Nations

           
pharmaceuticals-related oenses; establishment of legal responsibility


products; establishment of proportional punishments for natural persons
217
CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223
          
crimes.
3. Discussion
A conceptual vision of the grounds and measures of legal liability for illicit

component of a complex problem, consisting of security, economic, social,
management, and law enforcement issues. This determines the diversity of

          
        
 et al., 2022). In this regard, we could see the growing
importance of the pharmaceutical sector of the economy the production
of drugs and vaccines (Borysov, 2021), the acceleration of trade, and the


(United Nations, 2020). Since the start of the pandemic, this economic
direction has become the leader in the growth of business activity (Centre


           

for crime prevention (Borysov, 2021).
          
medicinal products as the most dangerous phenomenon, as the appearance
        

change the concept of organized criminal activity as a component of the
shadow economy, which is characterized by the development according
to general economic laws, as the main factor was the demand for scarce
medicine and public pressure on health care systems. In the conditions
of logistical complications, this became an impetus for the production


on Drugs and Crime, 2021).
          
et al., 2020), it was found that the development of Internet
         

          

218
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic
In this context, it must be emphasized that there is an inconsistency
of normative prescriptions regarding falsied medical product-related
crimes
     

became evident precisely during the conditions of the pandemic.
          
therefore administrative responsibility is established for their commission


There are proposals not to consider the use of medicines that have not

the other hand, it is proposed to establish legal liability for the impact of

At the same time, the experts point to the comprehensiveness of the
issues, related to the illicit trade in pharmaceuticals, that need to be resolved.
These include a) cybercrimes, the detection of which is complicated by the
corporate policy (Button, 2020) and technological features (Fiorella et al.,



was also rightly noted (, 2021).
Thus, one can say that the crimes of organized criminal structures have
       
the adaptation of the law enforcement system and maintenance of public
support (Ross, 2017). The main role in this aspect is played by society’s
           et al.,

a system of regulatory and institutional tools for combating illicit trade in

Conclusions
The conducted research allows us to draw many conclusions regarding

 
their commission.
It has been established that the illicit trade in pharmaceuticals is a type

severity, which are committed by organized criminal groups. The latter can
use legal mechanisms and legal entities. However, without establishing


CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223
It was proposed to develop such a model of law enforcement activities,
which is focused on criminalizing the trade in substandard (low-quality),
      
standards; establishing of proportional punishments for individuals and


agencies at the regional and international levels.
This study opens prospects for the development of safety standards in


A separate promising direction is the development of legal support for
international cooperation to counter transnational organized crime to

security.
Bibliographic References







    
       
         
       


D1%80%D0%B0%D0%BD%D1%82%D0%B8%D0%BD%D0%BD%
D0%B8%D1%85+%D0%BE%D0%B1%D0%BC%D0%B5%D0%B6%
D0%B5%D0%BD%D1%8C+%D0%BD%D0%B0+%D0%B5%D0%BA%




D0%B4%D0%B6%D0%B5%D0%BD%D0%BD%D1%8F+%D0%A6%



220
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic
         
        
    



     
       
        
economy. Research based on the results of in-depth interviews with
         




      
       

Vol. 76, No. 4, pp. 1187-1213.
      
         



          



       
     
eu/publications-events/publications/pandemic-profiteering-how-

        
       
  


       
      
221
CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223
        

  

pp. 101611.
          

        






Tareq. 2021. “Critical Success Factors and Traceability Technologies for
        
Protocols. Vol. 4, No. 4, p. 85.



  
02/02/2022.
       


       
         
 



“Big Data, Natural Language Processing, and Deep Learning to Detect


No. 3.
     
2022. “Extended Prescribing Roles for Pharmacists in Poland – A Survey
222
Mariia Shcherbina, Mykhailo Akimov, Iryna Ozerna, Ilgar Huseynov y Halyna Rossikhina
Legal Responsibility for Illicit Trade in Pharmaceuticals under Conditions of the Covid-19
Pandemic



heuristic model of controlling crimes by the powerful” Criminal Justice

      
        
normative and instrumental factors impact public willingness to support

   




         
the counterfeiting of medical products and similar crimes involving
    

02/02/2022.
          
       
      
 

        
    
       

  
02/02/2022.


      




      
223
CUESTIONES POLÍTICAS
Vol. 40 Nº 74 (2022): 207-223


         
        
        


       
      



        Available


www.luz.edu.ve
www.serbi.luz.edu.ve
www.produccioncienticaluz.org
Esta revista fue editada en formato digital y publicada
en octubre de 2022, por el Fondo Editorial Serbiluz,
Universidad del Zulia. Maracaibo-Venezuela
Vol.40 Nº 74